Paclitaxel-Eluting Stent for Treating Symptomatic Femoropopliteal PAD

In patients with symptomatic femoropopliteal PAD, use of polymer-coated, paclitaxel-eluting stents show superior 1-year primary patency.

Related Keywords

Boston ,Massachusetts ,United States , ,Boston Scientific ,Superficial Femoral ,Proximal Popliteal Artery ,